Collegium Pharmaceutical
COLL
COLL
72 hedge funds and large institutions have $307M invested in Collegium Pharmaceutical in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 38 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
13% less funds holding
Funds holding: 83 → 72 (-11)
56% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 16
72% less call options, than puts
Call options by funds: $149K | Put options by funds: $529K
Holders
72
Holding in Top 10
1
Calls
$149K
Puts
$529K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$6.62M | |
| 3 | +$4.63M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.79M |
| 5 |
Millennium Management
New York
|
+$3.29M |
Top Sellers
| 1 | -$7.99M | |
| 2 | -$3.77M | |
| 3 | -$2.14M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$2.01M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$1.09M |